The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia

Atherosclerosis

Volumn 229, Issue 2, 2013, Pages 348-355

  Choe, Nakwon ^a   Kwon, Jin Sook ^b   Kim, Ju Ryoung ^a   Eom, Gwang Hyeon ^a   Kim, Yongsook ^b   Nam, Kwang Il ^a   Ahn, Youngkeun ^b   Kee, Hae Jin ^b   Kook, Hyun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Atherosclerosis; Leucine rich repeat (in flightless 1) interacting protein 1; MiR 132; Neointimal hyperplasia; Vascular smooth muscle cells

Indexed keywords

ALPHA ACTIN; CARRIER PROTEINS AND BINDING PROTEINS; LEUCINE RICH REPEAT INTERACTING PROTEIN 1; MICRORNA 132; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN P27; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BIOINFORMATICS; CAROTID ARTERY INJURY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE; SMOOTH MUSCLE FIBER; THROMBOCYTE FUNCTION; VASCULAR SMOOTH MUSCLE;

ATHEROSCLEROSIS; LEUCINE-RICH REPEAT (IN FLIGHTLESS 1) INTERACTING PROTEIN-1; MIR-132; NEOINTIMAL HYPERPLASIA; VASCULAR SMOOTH MUSCLE CELLS;

ACTINS; ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; BASE SEQUENCE; CATHETERIZATION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE MODELS, ANIMAL; HYPERPLASIA; MALE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; RATS; RATS, SPRAGUE-DAWLEY; RNA-BINDING PROTEINS;

EID: 84880412690     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.05.009     Document Type: Article

References (30)

1. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
2. Robert A., McDonald A.H., MacLean Margaret R., Morrell Nicholas W., Baker Andrew H. MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling. Cardiovasc Res 2012, 93:594-604.
3. Cordes K.R., Sheehy N.T., White M.P., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
4. Ji R., Cheng Y., Yue J., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007, 100:1579-1588.
5. Liu X., Cheng Y., Chen X., et al. MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. JBiol Chem 2011, 286:42371-42380.
6. Liu X., Cheng Y., Zhang S., et al. Anecessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009, 104:476-487.
7. Wang Y.S., Wang H.Y., Liao Y.C., et al. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation. Cardiovasc Res 2012, 95:517-526.
8. Villeneuve L.M., Kato M., Reddy M.A., et al. Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes 2010, 59:2904-2915.
9. Formosa A., Lena A.M., Markert E.K., et al. DNA methylation silences miR-132 in prostate cancer. Oncogene 2012.
10. Zhang S., Hao J., Xie F., et al. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis 2011, 32:1183-1189.
11. Mellios N., Sugihara H., Castro J., et al. miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity. Nat Neurosci 2011, 14:1240-1242.
12. Anand S., Majeti B.K., Acevedo L.M., et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 2010, 16:909-914.
13. Katare R., Riu F., Mitchell K., et al. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 2011, 109:894-906.
14. Lo I.C., Lin T.M., Chou L.H., et al. Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells. Cardiovasc Res 2009, 81:771-779.
15. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes invivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619.
16. Li Q., Dashwood W.M., Zhong X., et al. Bcl-2 overexpression in PhIP-induced colon tumors: cloning of the rat Bcl-2 promoter and characterization of a pathway involving beta-catenin, c-Myc and E2F1. Oncogene 2007, 26:6194-6202.
17. Khachigian L.M., Santiago F.S., Rafty L.A., et al. GC factor 2 represses platelet-derived growth factor A-chain gene transcription and is itself induced by arterial injury. Circ Res 1999, 84:1258-1267.
18. Goodall A.H., Burns P., Salles I., et al. Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function. Blood 2010, 116:4646-4656.
19. Ariake K., Ohtsuka H., Motoi F., et al. GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation. Cancer Lett 2012, 325:99-107.
20. Orr A.W., Hastings N.E., Blackman B.R., et al. Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. JVasc Res 2010, 47:168-180.
21. Bochaton-Piallat M.L., Gabbiani G. Modulation of smooth muscle cell proliferation and migration: role of smooth muscle cell heterogeneity. Handb Exp Pharmacol 2005, 645-663.
22. Nahid M.A., Satoh M., Chan E.K. MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 2011, 8:388-403.
23. Jin W., Reddy M.A., Chen Z., et al. Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. JBiol Chem 2012, 287:15672-15683.
24. Park J.K., Henry J.C., Jiang J., et al. miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun 2011, 406:518-523.
25. Andres V., Urena J., Poch E., et al. Role of Sp1 in the induction of p27 gene expression in vascular smooth muscle cells invitro and after balloon angioplasty. Arterioscler Thromb Vasc Biol 2001, 21:342-347.
26. Yang Z.Y., Simari R.D., Perkins N.D., et al. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci U S A 1996, 93:7905-7910.
27. Liu Y.T., Yin H.L. Identification of the binding partners for flightless I, A novel protein bridging the leucine-rich repeat and the gelsolin superfamilies. JBiol Chem 1998, 273:7920-7927.
28. Suriano A.R., Sanford A.N., Kim N., et al. GCF2/LRRFIP1 represses tumor necrosis factor alpha expression. Mol Cell Biol 2005, 25:9073-9081.
29. Gu Y.H., Sivam G. Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen-independent prostate cancer PC-3 cells. JMed Food 2006, 9:196-204.
30. Wilson S.A., Brown E.C., Kingsman A.J., et al. TRIP: a novel double stranded RNA binding protein which interacts with the leucine rich repeat of flightless I. Nucleic Acids Res 1998, 26:3460-3467.